3 months - $299 Ideal for patients at a higher non-starter dose or wanting to titrate up to a higher therapeutic dose
Some already suspect their testosterone is low
You can log symptoms, hydration, meals and mood with just a few taps
Fatima Cody Stanford, an associate professor of medicine and pediatrics and obesity medicine physician-scientist at the Massachusetts General Hospital and Harvard Medical School, said that as someone who has treated more than 3,000 patients with obesity, she does have strong data supporting the heterogeneity of response to GLP-1R agonists in practice
The company noted the candidate's competitive safety profile and sustained efficacy over 28 weeks, with plans to advance it into Phase 3 trials in 2026
Constipation and stomach ache were reported more frequently in the active group (10%) compared to the placebo group (3%)